117 related articles for article (PubMed ID: 29947178)
1. Procalcitonin as Marker of Recurrent Medullary Thyroid Carcinoma: A Systematic Review and Meta-Analysis.
Trimboli P; Giovanella L
Endocrinol Metab (Seoul); 2018 Jun; 33(2):204-210. PubMed ID: 29947178
[TBL] [Abstract][Full Text] [Related]
2. Procalcitonin as an Alternative Tumor Marker of Medullary Thyroid Carcinoma.
Giovanella L; Garo ML; Ceriani L; Paone G; Campenni' A; D'Aurizio F
J Clin Endocrinol Metab; 2021 Nov; 106(12):3634-3643. PubMed ID: 34382653
[TBL] [Abstract][Full Text] [Related]
3. Procalcitonin for detecting medullary thyroid carcinoma: a systematic review.
Trimboli P; Seregni E; Treglia G; Alevizaki M; Giovanella L
Endocr Relat Cancer; 2015 Jun; 22(3):R157-64. PubMed ID: 25934688
[TBL] [Abstract][Full Text] [Related]
4. Reliability of core needle biopsy as a second-line procedure in thyroid nodules with an indeterminate fine-needle aspiration report: a systematic review and meta-analysis.
Trimboli P; Giovanella L
Ultrasonography; 2018 Apr; 37(2):121-128. PubMed ID: 29427991
[TBL] [Abstract][Full Text] [Related]
5. The role of procalcitonin in the follow-up of medullary thyroid cancer.
Censi S; Manso J; Benvenuti T; Piva I; Iacobone M; Mondin A; Torresan F; Basso D; Crivellari G; Zovato S; Mian C
Eur Thyroid J; 2023 Feb; 12(1):. PubMed ID: 36476491
[TBL] [Abstract][Full Text] [Related]
6. Salivary and serum biomarkers of inflammation in a man with metastatic medullary thyroid carcinoma and hyperreactive gingiva: a fourteen year odyssey.
Redman RS; Bayley NC; Nylén ES
Biotech Histochem; 2019 Aug; 94(6):389-397. PubMed ID: 31423894
[TBL] [Abstract][Full Text] [Related]
7. Circulating procalcitonin and cleavage products in septicaemia compared with medullary thyroid carcinoma.
Ittner L; Born W; Rau B; Steinbach G; Fischer JA
Eur J Endocrinol; 2002 Dec; 147(6):727-31. PubMed ID: 12457446
[TBL] [Abstract][Full Text] [Related]
8. Prevalence and significance of indeterminate calcitonin values in patients with thyroid nodules: A systematic review and meta-analysis.
Piticchio T; Frasca F; Trimboli P
Rev Endocr Metab Disord; 2023 Aug; 24(4):685-694. PubMed ID: 37254023
[TBL] [Abstract][Full Text] [Related]
9. Detection rate of FNA cytology in medullary thyroid carcinoma: a meta-analysis.
Trimboli P; Treglia G; Guidobaldi L; Romanelli F; Nigri G; Valabrega S; Sadeghi R; Crescenzi A; Faquin WC; Bongiovanni M; Giovanella L
Clin Endocrinol (Oxf); 2015 Feb; 82(2):280-5. PubMed ID: 25047365
[TBL] [Abstract][Full Text] [Related]
10. Diagnostic accuracy of routine calcitonin measurement for the detection of medullary thyroid carcinoma in the management of patients with nodular thyroid disease: a meta-analysis.
Vardarli I; Weber M; Weidemann F; Führer D; Herrmann K; Görges R
Endocr Connect; 2021 Mar; 10(3):358-370. PubMed ID: 33638941
[TBL] [Abstract][Full Text] [Related]
11. Diagnostic value of selected biochemical markers in the detection of recurrence of medullary thyroid cancer - comparison of calcitonin, procalcitonin, chromogranin A, and carcinoembryonic antigen.
Woliński K; Kaznowski J; Klimowicz A; Maciejewski A; Łapińska-Cwojdzińska D; Gurgul E; Car AD; Fichna M; Gut P; Gryczyńska M; Ruchała M
Endokrynol Pol; 2017; 68(4):434-437. PubMed ID: 28585679
[TBL] [Abstract][Full Text] [Related]
12. Procalcitonin assay in systemic inflammation, infection, and sepsis: clinical utility and limitations.
Becker KL; Snider R; Nylen ES
Crit Care Med; 2008 Mar; 36(3):941-52. PubMed ID: 18431284
[TBL] [Abstract][Full Text] [Related]
13. Novel acquisitions in the diagnosis of medullary thyroid carcinoma.
Trimboli P; Crescenzi A; Saggiorato E; Treglia G; Giovanella L
Minerva Endocrinol; 2017 Sep; 42(3):238-247. PubMed ID: 27808486
[TBL] [Abstract][Full Text] [Related]
14. Can procalcitonin be useful for medullary thyroid cancer?
Kaczka K; Mikosiński S; Fendler W; Jałocha-Kaczka A; Pomorski L
Endokrynol Pol; 2010; 61(5):430-6. PubMed ID: 21049453
[TBL] [Abstract][Full Text] [Related]
15. Procalcitonin levels predict clinical course and progression-free survival in patients with medullary thyroid cancer.
Walter MA; Meier C; Radimerski T; Iten F; Kränzlin M; Müller-Brand J; de Groot JW; Kema IP; Links TP; Müller B
Cancer; 2010 Jan; 116(1):31-40. PubMed ID: 19890958
[TBL] [Abstract][Full Text] [Related]
16. Management of thyroid cancer: United Kingdom National Multidisciplinary Guidelines.
Mitchell AL; Gandhi A; Scott-Coombes D; Perros P
J Laryngol Otol; 2016 May; 130(S2):S150-S160. PubMed ID: 27841128
[TBL] [Abstract][Full Text] [Related]
17. Routine measurement of serum calcitonin is useful for early detection of medullary thyroid carcinoma in patients with nodular thyroid diseases.
Hahm JR; Lee MS; Min YK; Lee MK; Kim KW; Nam SJ; Yang JH; Chung JH
Thyroid; 2001 Jan; 11(1):73-80. PubMed ID: 11272100
[TBL] [Abstract][Full Text] [Related]
18. Routine measurement of serum calcitonin in nodular thyroid diseases allows the preoperative diagnosis of unsuspected sporadic medullary thyroid carcinoma.
Pacini F; Fontanelli M; Fugazzola L; Elisei R; Romei C; Di Coscio G; Miccoli P; Pinchera A
J Clin Endocrinol Metab; 1994 Apr; 78(4):826-9. PubMed ID: 8157706
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of Vandetanib in Treating Locally Advanced or Metastatic Medullary Thyroid Carcinoma According to RECIST Criteria: A Systematic Review and Meta-Analysis.
Trimboli P; Castellana M; Virili C; Giorgino F; Giovanella L
Front Endocrinol (Lausanne); 2018; 9():224. PubMed ID: 29774010
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
